|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 332.00 EUR | -0.75% |
|
+1.84% | -7.13% |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
| 07-21 | Despite the escalation in the Middle East, European stocks stay the course |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 350 | 384 | 383.5 |
| Spread/Res. | -5.14% | -13.54% | -13.43% |
| Spread/Supp. | +4.73% | +4.73% | +7.10% |
| Support | 317 | 317 | 310 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
Select your edition
All financial news and data tailored to specific country editions
